Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming (PHAR) Net Cash Flow (2019 - 2023)

Historic Net Cash Flow for Pharming (PHAR) over the last 5 years, with Q2 2023 value amounting to -$104.9 million.

  • Pharming's Net Cash Flow fell 115540.69% to -$104.9 million in Q2 2023 from the same period last year, while for Mar 2024 it was -$104.9 million, marking a year-over-year decrease of 62891630.21%. This contributed to the annual value of $77536.7 for FY2020, which is 10045.07% up from last year.
  • As of Q2 2023, Pharming's Net Cash Flow stood at -$104.9 million, which was down 115540.69% from -$2.7 million recorded in Q4 2022.
  • Over the past 5 years, Pharming's Net Cash Flow peaked at $14.0 million during Q3 2020, and registered a low of -$104.9 million during Q2 2023.
  • Over the past 5 years, Pharming's median Net Cash Flow value was -$2.7 million (recorded in 2022), while the average stood at -$17.1 million.
  • The largest annual percentage gain for Pharming's Net Cash Flow in the last 5 years was 16100.76% (2022), contrasted with its biggest fall of 12597143.41% (2022).
  • Quarter analysis of 5 years shows Pharming's Net Cash Flow stood at -$90.6 million in 2019, then soared by 100.15% to $134280.4 in 2020, then crashed by 108.19% to -$11003.9 in 2021, then tumbled by 24027.9% to -$2.7 million in 2022, then plummeted by 3851.71% to -$104.9 million in 2023.
  • Its last three reported values are -$104.9 million in Q2 2023, -$2.7 million for Q4 2022, and -$7.3 million during Q3 2022.